Skip to content

Screen Your Way Study Protocol: Cervical screening via Human Papillomavirus (HPV) self-collection for Aboriginal and Torres Strait Islander women and people with a cervix

Screen Your Way Study Protocol: Assessing the impact of community driven models on cervical screening via HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12625001134415
Acronym
SYW
Enrollment
2000
Registered
2025-10-16
Start date
2024-02-05
Completion date
2025-08-08
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Screen Your Way aims to increase cervical screening participation among under-and never screened Aboriginal and Torres Strait Islander women and people with a cervix. This will be done in partnership with Aboriginal Community Controlled Organisations (ACCHOs) by putting strategies in place to increase self-collection of cervical screening. The ultimate goal is to reduce cervical cancer incidence. The study will work with ACCHOs to co-design ways to increase self-collection, put them into practice, and evaluate how effective they are. The research team will work together with services and their community to develop strategies to support increasing the use of self-collection for cervical screening and other strategies to increase cervical screening. These tailored strategies will be put into practice (implemented) for 12 months. Findings from at least six services in NSW, QLD and NT will be combined and used to inform National scale up of self-collection and help other ACCHOS to roll-out self-collection.

Interventions

This implementation study aims to embed Human Papillomavirus (HPV) self-collection into usual care as part of the National Cervical Screening Program within Aboriginal and Torres Strait Islander Community Controlled Health Organisations (ACCHO) and/or primary care organisations whose context is similar to that of an ACCHO. This will be achieved by co-designing, implementing, and evaluating models of care tailored to local needs. ACCHOs will be recruited to participate in this before and after

This implementation study aims to embed Human Papillomavirus (HPV) self-collection into usual care as part of the National Cervical Screening Program within Aboriginal and Torres Strait Islander Community Controlled Health Organisations (ACCHO) and/or primary care organisations whose context is similar to that of an ACCHO. This will be achieved by co-designing, implementing, and evaluating models of care tailored to local needs. ACCHOs will be recruited to participate in this before and after implementation study. After recruitment to the study, strategies will be co-designed with each service tailored to meet local needs and then implemented by the service as part of usual primary care as part of the National Cervical Screening Program for 12 months. The research team will work with nominated staff at participating services to facilitate co-design workshops, the design of locally tailored strategies and to engage with community members as determined locally in line with keys principles of co-design with Aboriginal and Torres Strait Islander peoples including leadership, a culturally grounded approach, respect, benefit to community, inclusive partnerships and transparency and evaluation and reciprocity. Co-design occurred over a period of up to 6 months prior to implementation and varied based on local service needs, capacities, and community priorities. Each participating site has co-designed and will implement locally tailored strategies to improve cervical screening participation among Aboriginal and Torres Strait Islander women and people with a cervix. These strategies reflect community priorities and service capacities, and were developed collaboratively between health services, community members, and the research team. Rather than being prescriptive, the strategies are designed to enhance usual clinical care and allow each service to select and adapt approaches that best suit their local context. This includes choosing from a suite of options based on identified needs, existing resources, and community preferences. The flexible design ensures that HPV self-collection is embedded into routine care sustainably. Examples of strategies include: 1. Community engagement strategies a. Community awareness campaigns: Co-designed posters, brochures, and social media content developed jointly by service staff and the research team. These materials promote the choice of HPV self-collection directly to ACCHO clients. b. Health promotion: Community events and campaigns hosted by ACCHO to raise awareness of HPV self-collection and provide education, and encourage clients to participate in cervical screening. 2. Participant level strategies a. Follow-up reminders: Modification of SMS or phone call reminders for clients who are due for cervical screening with the offer of self-collection. b. Incentives: Participants who complete cervical screening are offered a small incentive, such as a gift card or wellbeing pack, to acknowledge their participation and encourage uptake. Incentives are provided immediately after screening by service staff, either during consultations or at community events. 3. Workforce level strategies a. Staff education and training: Delivered by the research team, these sessions cover cervical screening guidelines, self-collection procedures, and communication strategies for ACCHO clients. Training is provided in-person or online depending on site needs. b. Clinical champions: Identified within each service to support implementation, mentor staff, and liaise with the research team. 4. Health service level strategies: a. Data Audit and Cleaning: Practice staff and/or research support teams conduct detailed audits of cervical screening data within practice management software to identify eligible participants and ensure data accuracy. This process involves checking individual client records against the National Cancer Screening Register (NCSR) and manually updating local records where discrepancies are found. The aim is to create a reliable and up-to-date screening register within each service, which supports targeted outreach and follow-up, and ensures that screening invitations are based on accurate information. b. Workflow Integration: Services have integrated cervical screening checks into routine clinical workflows to promote opportunistic screening. This includes embedding prompts into appointment systems and clinical templates to ensure that cervical screening status is reviewed and self-collection is offered during regular visits, such as 715 health checks or chronic disease reviews. Staff are encouraged to offer screening as part of everyday care, supported by incentives for participants and streamlined documentation processes to reduce administrative burden and improve uptake.

Sponsors

Yardhura Walani, The Australian National University
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Primary purpose
Prevention

Eligibility

Sex/Gender
All
Age
25 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

Services will be purposefully sampled in line with the following eligibility criteria: 1. Are an ACCHO, or a primary healthcare organisation with a majority of clients being Aboriginal and Torres Strait Islander people whose context is similar to that of an ACCHO (referred to as ACCHOs hereinafter) 2. Are located in Qld, NSW or the NT 3. Have 120 or more Aboriginal and Torres Strait Islander women or people with a cervix aged 25-74 years who are active clients (defined as three or more clinic visits in past two years) 4. Have at least one cervical screening certified health professional 5. Consent to provide screening data related to cervical screening.

Exclusion criteria

Services will be excluded if they are unable to meet the inclusion criteria or if they are involved in other trials relating to cervical screening given the potential to contaminate results.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026